C'mon, quest, has anything ever happened with this company that we think "should" happen? A pain indication sure would benefit us, but who knows? I will believe it when i see it.
Hi there, I'm a former TTNP investor (as far back as when it was TTP) who is thinking about getting back in (I sold back in '13 after the FDA screwed them over on probuphine).
I apologize if this has been gone over before, but if Braeburn was to go for a pain indication for probuphine, where in the process would they start at? I assume no Phase I or Phase II required, but would it require a full round of Phase III trials?
News 
Market Data 
Discover 
